Lina Tang

Fujian Medical University — China

Medicine · Health Sciences

25h-index2.6kcitations111works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(45), Lung Cancer Treatments and Mutations(18), Radiopharmaceutical Chemistry and Applications(10), Vascular Tumors and Angiosarcomas(10), Colorectal Cancer Treatments and Studies(9)

Publications111 total

Supplementary Table S3 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Supplementary Table S2 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Supplementary Figure S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Supplementary Table S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Supplementary Table S4 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
Supplementary Table S5 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2025Open Access
The Effects of Prenatal A lkylphenols Exposure on Offspring Neurodevelopment: Evidence-Based Risk Assessment with The TRAE Strategy
2025
A Novel Multi-Sensor Fusion SLAM Approach for Mobile Robot
Unmanned Systems·2025
Adipocytes Promote Cisplatin Resistance through Secreting A1BG and Regulating NAMPT/PARP1 Axis‐Mediated DNA Repair in Osteosarcoma
Advanced Science·2025· 2 citedOpen Access
Ultrasound-responsive release of CD39 inhibitor overcomes adenosine-mediated immunosuppression in triple-negative breast cancer
Journal of Controlled Release·2025· 3 cited
[Therapeutic potential of ion channel modulation in Alzheimer's disease].
PubMed·2025
1807P Spatial analyses revealed MMP7 as the biomarker of tumor boundary correlated with immune resistance in small cell lung cancer
Annals of Oncology·2024
Neuroprotective Effects of AER-271 in a tMCAO Mouse Model: Modulation of Autophagy, Apoptosis, and Inflammation
Inflammation·2024
Alterations in Serum Lipids and Lipoproteins Induced by Neoadjuvant Chemotherapy in Patients with Osteosarcoma around the Knee Joint: A Retrospective Analysis
Current Medical Science·2024
AB0469 EFFICACY AND SAFETY OF SECUKINUMAB IN CHINESE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: WEEK 16 RESULTS FROM A PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED BRIDGING STUDY IN CHINA
Annals of the Rheumatic Diseases·2024
Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis
Cellular Oncology·2024· 11 citedOpen Access
A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas
BMC Medicine·2023· 20 citedOpen Access
Supplementary Figure S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2023Open Access
Supplementary Figure S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2023Open Access
Supplementary Table S3 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Zan Shen(40), Yang Yao(31), Aina He(24), Wei‐Xiang Qi(23), Feng Lin(16), Wenxi Yu(14), Yuanjue Sun(14), Daliu Min(11), Qingcheng Yang(8), Haiyan Hu(8), Shuier Zheng(8), Hongtao Li(6), Yang Dong(5), Zhichang Zhang(5), Jianjun Zhang(5), Yuanjue Sun(5), Yang Yao(5), Hui Zhao(5), Chenliang Zhou(4), Lin Feng(4)